Before taking the corner office at ViCentra, Arnold held leadership roles at Medtronic, Procept BioRobotics ... ViCentra launched its hybrid closed-loop automated insulin delivery system that uses the ...

HYDERABAD Feb 25 (Reuters) - Medical device maker Medtronic (MDT.N), opens new tab is looking at options to modify its global manufacturing footprint as part of efforts to mitigate any impact of U ...

Seventeen years before Medtronic’s recent FDA approval for the world’s first adaptive deep brain stimulation (DBS) system for Parkinson’s disease, Scott Stanslaski was just starting his work on the ...

Shortly after obtaining a greenlight in Europe and after more than 10 years in development, Medtronic has now received the FDA’s approval for its adaptive, closed-loop neurostimulation approach ...

Noteworthy is Medtronic's FDA-cleared smart insulin pen that integrates glucose sensor data, utilizing AI to personalize insulin dosing. From an investor’s perspective, the healthcare sector ...

A clinician uses Medtronic's pulsed field ablation system for treating atrial fibrillation last month. On Tuesday, Medtronic reported adjusted quarterly net profit of $1.8 billion on $8.3 billion ...

Medtronic shares tumbled after the medical device maker’s sales came in short of analysts' forecasts. Major U.S. indexes wavered between gains and losses at midday Tuesday ahead of fresh ...

VCG / Contributor / Getty Images Medtronic shares slumped Tuesday after the medical device maker missed sales forecasts. The revenue miss came as sales of its stapling and blood oxygen management ...

Medtronic posted a strong profit for Q3 of fiscal ... its customer base and strengthened its continuous glucose monitor (CGM) attachment rates, as per the earnings release.

Medtronic missed Wall Street's fiscal 2025 Q3 revenue estimate but beat earnings expectations. The company's revenue miss appears to be primarily related to a temporary change in distributor ...